Porphyrias, porphyrins and hepatocellular cancer

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1).

European journal of cancer (Oxford, England : 1990)·2018

Adipose-tissue concentrations of dioxins and dibenzofurans in potentially exposed patients with malignant-lymphoma or sarcoma.

Oncology reports·2011

Is hairy-cell leukemia more common among farmers - a pilot-study.

Oncology reports·2011

Identification of the flame retardants polybrominated diphenyl ethers in adipose tissue from patients with non-Hodgkin's lymphoma in Sweden.

Oncology reports·2011

Metaanalysis of 4 Swedish case-control studies on exposure to pesticides as risk-factor for soft-tissue sarcoma including the relation to tumor-localization and histopathological type.

International journal of oncology·2011

Colon-cancer and dietary habits - a case-control study.

International journal of oncology·2011

Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials.

British journal of cancer·2026

Photodynamic immune stimulation eradicates primary pigmented melanoma and induces long-lasting anti-tumor immunity.

British journal of cancer·2026

Healthy lifestyle and cancer risk: a pan-cancer analysis in the UK Biobank prospective cohort.

British journal of cancer·2026

Unlocking the clock: a systematic review and meta-analysis on optimizing immune checkpoint inhibitor timing for advanced solid tumors.

British journal of cancer·2026

Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

British journal of cancer·2026

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

British journal of cancer·2026

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Frontiers in medicine·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Current vascular pharmacology·2026

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

The American journal of surgical pathology·2026

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Virus genes·2026

Related Experiment Videos

Porphyrias, porphyrins and hepatocellular cancer

Related Concept Videos

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1).

Adipose-tissue concentrations of dioxins and dibenzofurans in potentially exposed patients with malignant-lymphoma or sarcoma.

Is hairy-cell leukemia more common among farmers - a pilot-study.

Identification of the flame retardants polybrominated diphenyl ethers in adipose tissue from patients with non-Hodgkin's lymphoma in Sweden.

Metaanalysis of 4 Swedish case-control studies on exposure to pesticides as risk-factor for soft-tissue sarcoma including the relation to tumor-localization and histopathological type.

Colon-cancer and dietary habits - a case-control study.

Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials.

Photodynamic immune stimulation eradicates primary pigmented melanoma and induces long-lasting anti-tumor immunity.

Healthy lifestyle and cancer risk: a pan-cancer analysis in the UK Biobank prospective cohort.

Unlocking the clock: a systematic review and meta-analysis on optimizing immune checkpoint inhibitor timing for advanced solid tumors.

Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Related Experiment Videos

Porphyrias, porphyrins and hepatocellular cancer

Related Concept Videos

Related Articles